The Itch: Allergies, Asthma, Eczema & Immunology22 Elo 2024

#82 -The Future of Chronic Spontaneous Urticaria Treatments (Dupilumab, Remibrutinib, and Barzolvolimab.)

There’s never been a better time to be a CSU patient, with cutting-edge therapies and revolutionary treatments just around the corner. As research accelerates, new and promising options that could significantly improve the quality of life for those living with Chronic Spontaneous Urticaria are coming to market.

In this episode, Dr. Matthew Zirwas joins us to discuss the latest advancements in treating CSU, offering invaluable insights into both current and emerging treatment options. With his extensive experience and patient-centred approach, Dr. Zirwas breaks down the complexities of CSU and highlights how these new therapies can make a real difference.

This podcast was made in partnership with Allergy & Asthma Network. We thank Novartis for sponsoring this podcast.

What We Cover in Our Episode About Emerging Chronic Spontaneous Urticaria Treatments:

How Dr. Zirwas explains CSU to his patients: Discover the patient-friendly explanations that help demystify CSU and empower patients to learn more about their disease.
When to start with a biologic: Learn about the decision-making process for initiating biologic therapies like Xolair (omalizumab) and when they are most appropriate.
The new medications coming to market: Get an overview of the latest advancements, including:
- Dupixent (dupilumab): A biologic administered via injection that targets key pathways in the inflammatory response.
- Remibrutinib: A BTK (Bruton tyrosine kinase) inhibitor available as a pill that blocks a crucial enzyme in mast cell activation.
- Barzolvolimab: A promising biologic that targets the C KIT receptor on mast cells to reduce their number.
Shared decision-making with these medications: Explore strategies for choosing the most appropriate treatment in a rapidly evolving therapeutic landscape.
Research into the underlying cause of CSU: What’s happening on the research front to uncover the root causes of CSU.

About Our Guest

Dr. Matthew Zirwas, MD, is a board-certified dermatologist and a nationally recognized expert in allergy patch testing, psoriasis, and eczema. He founded the Bexley Dermatology Research Clinic, offering patients access to the latest treatment options before they are widely available. Dr. Zirwas also serves as a dermatologic advisor for several companies, including ALL Laundry Detergent and Cerave, and contributes to Women’s Health Magazine. Learn more about Dr. Zirwas.

More resources about chronic spontaneous urticaria:

Chronic Urticaria Management, Resources & Glossary of Terms: https://allergyasthmanetwork.org/health-a-z/chronic-urticaria/management-and-resources/
What is Chronic Urticaria: https://allergyasthmanetwork.org/health-a-z/chronic-urticaria/
More information about Omalizumab (Xolair): https://www.xolair.com/chronic-spontaneous-urticaria.html

Disclaimer: This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(174)

#172 - Why Needing Systemic Steroids for Asthma Is a Warning Sign

Needing oral steroids for your asthma is a signal, not just a setback. It could be a sign that your asthma is not actually under control, even if you feel like you're managing it day to day. Dr. Wes S...

27 Elo 39min

#171 - Rescue Inhaler Changes in the Newest Asthma Guidelines

For decades, the rescue inhaler was simple: feel tight, take a puff, breathe easier. But the newest asthma guidelines have changed what's actually recommended inside that inhaler, shifting away from p...

21 Elo 42min

#170 - When Asthma Peak Week Hits Adults

Most asthma peak week coverage focuses on kids heading back to school. But adults with asthma are just as much at risk, and often don't realize it until they're already in trouble. Kortney and Dr. Pa...

13 Elo 29min

#169 - What a School Nurse Wants Parents to Know About Asthma Peak Week

Every September, doctors see a jump in asthma attacks and ER visits. It's called Asthma Peak Week, and it usually hits the third week of September, right when families are settling into their school r...

6 Elo 41min

#168 - Wildfire Smoke and Your Lungs, What You Need to Know

Wildfire smoke used to feel like someone else's problem. Now it can show up on air quality alerts hundreds of miles from any actual fire, and for anyone with asthma, that hazy sky can mean real troubl...

30 Heinä 23min

#167 - How Is Chronic Rhinosinusitis Without Nasal Polyps Diagnosed and Treated?

Chronic rhinosinusitis without nasal polyps (CRSsNP) is the type that makes up most chronic sinusitis cases. It's often mistaken for allergies, a lingering cold, or migraines, which can delay a proper...

24 Heinä 28min

#166 - How Pregnancy and Your Baby's Gut Microbiome Play a Role in Food Allergy Prevention

Food allergy prevention is something most families think about once a baby starts eating. But the gut microbiome begins developing before birth, and what happens during pregnancy matters for the devel...

16 Heinä 21min

#165: Gut Microbiome's Role in Food Allergies

You have probably heard the word "microbiome", but what does it actually mean for someone living with a food allergy? Dr. Carina Venter, a registered dietitian, joins us to break down the gut’s role i...

9 Heinä 35min